The present work describes, for the first time, an eco-friendly capillary zone electrophoresis (CZE) methodology for determining apixaban (APX), an oral anticoagulant. Separation was carried out using a fused silica capillary with an applied voltage of 20 kV and hydrodynamic injection for 5 s at 50 mbar. The electrolyte system consisted of 50 mM sodium borate at pH 8.0. The method was validated as recommended by ICH, establishing selectivity, linearity, precision, accuracy, and robustness. The analytical procedure was linear in the range of 10–125 µg mL−1 (r = 0.999). The limits of detection and quantification were determined to be 1.77 µg mL−1 and 5.37 µg mL−1, respectively. Precision was evaluated by relative standard deviation (RSD), with an intra-day RSD (n = 6) of 0.96% and an inter-day RSD (n = 18) of 4.42%. The average recovery rates for the pharmaceutical samples were excellent, ranging from 98.03% to 101.01%, with an RSD of 1.51%. Moreover, the green profile of the method was evaluated using the National Environmental Methods Index (NEMI), Analytical Eco-Scale, Green Analytical Procedure Index (GAPI), and Analytical GREEnness Metric (AGREE) assessment tools. The results suggest that the CZE method aligns with the principles of green chemistry, offering a greener alternative for the routine analysis of APX quality control. Also, the method presents a low-cost analysis, using fewer organic solvents and minimizing waste generation compared to techniques commonly used in routine analysis.
A green method by capillary electrophoresis (CE) is described for the first time for the determination of dapagliflozin (DAPA), an oral hypoglycemic drug approved for the treatment of Type 2 diabetes mellitus. The effects of different analytical conditions were evaluated, including the concentration and pH of the background electrolyte (BGE), sample injection time, applied voltage, as well as capillary temperature. The method was validated by establishing the linearity, intra‐ and interday precisions (relative standard deviation, RSD%), accuracy, and robustness. The analytical procedure was linear in the range of 50–175 µg mL −1 ( R2 > 0.999), with the limit of detection (LOD) and limit of quantitation (LOQ) of 6.2 and 18.8 µg mL −1 , respectively. Precision had an intraday RSD of 2.55% and an interday RSD of 2.52%. The average recovery rates for the pharmaceutical samples ranged from 101.22% to 104.63%, with an RSD of 0.88%. Additionally, the CE method was compared to a high‐performance liquid chromatography (HPLC) method for quantifying DAPA, and their green profiles were assessed by the Analytical Greenness Metric (AGREE), confirming the eco‐friendliness of the CE technique. The methodology is suitable for determining DAPA in tablets; CE provides a greener alternative due to low‐cost analysis using fewer organic solvents and minimizing waste generation.